“The reason that we’re concerned about it (Candida auris) is because these organisms seem to be able to transmit between patients very efficiently within hospitals and because they have intrinsic resistance to the antifungal medication that we would typically use for a patient that has an invasive yeast infection,” said Ilan Schwartz, an infectious disease physician and assistant professor at the University of Alberta in Edmonton.